1 Study Coverage 1.1 Inflammatory Skin Diseases Drugs Revenue in Inflammatory Skin Diseases Drugs Business (2017-2022) & (US$ Million) Introduction 1.2 Global Inflammatory Skin Diseases Drugs Outlook 2017 VS 2022 VS 2028 1.2.1 Global Inflammatory Skin Diseases Drugs Market Size for the Year 2017-2028 1.2.2 Global Inflammatory Skin Diseases Drugs Market Size for the Year 2017-2028 1.3 Inflammatory Skin Diseases Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Inflammatory Skin Diseases Drugs in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Inflammatory Skin Diseases Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Inflammatory Skin Diseases Drugs Market Dynamics 1.4.1 Inflammatory Skin Diseases Drugs Industry Trends 1.4.2 Inflammatory Skin Diseases Drugs Market Drivers 1.4.3 Inflammatory Skin Diseases Drugs Market Challenges 1.4.4 Inflammatory Skin Diseases Drugs Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Inflammatory Skin Diseases Drugs by Type 2.1 Inflammatory Skin Diseases Drugs Market Segment by Type 2.1.1 Retinoids 2.1.2 Corticosteroids 2.1.3 Calcineurin Inhibitors 2.1.4 Others 2.2 Global Inflammatory Skin Diseases Drugs Market Size by Type (2017, 2022 & 2028) 2.3 Global Inflammatory Skin Diseases Drugs Market Size by Type (2017-2028) 2.4 United States Inflammatory Skin Diseases Drugs Market Size by Type (2017, 2022 & 2028) 2.5 United States Inflammatory Skin Diseases Drugs Market Size by Type (2017-2028) 3 Inflammatory Skin Diseases Drugs by Application 3.1 Inflammatory Skin Diseases Drugs Market Segment by Application 3.1.1 Hospital Pharmacies 3.1.2 Retail Pharmacies 3.1.3 Online Pharmacies 3.2 Global Inflammatory Skin Diseases Drugs Market Size by Application (2017, 2022 & 2028) 3.3 Global Inflammatory Skin Diseases Drugs Market Size by Application (2017-2028) 3.4 United States Inflammatory Skin Diseases Drugs Market Size by Application (2017, 2022 & 2028) 3.5 United States Inflammatory Skin Diseases Drugs Market Size by Application (2017-2028) 4 Global Inflammatory Skin Diseases Drugs Competitor Landscape by Company 4.1 Global Inflammatory Skin Diseases Drugs Market Size by Company 4.1.1 Top Global Inflammatory Skin Diseases Drugs Companies Ranked by Revenue (2021) 4.1.2 Global Inflammatory Skin Diseases Drugs Revenue by Player (2017-2022) 4.2 Global Inflammatory Skin Diseases Drugs Concentration Ratio (CR) 4.2.1 Inflammatory Skin Diseases Drugs Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Inflammatory Skin Diseases Drugs in 2021 4.2.3 Global Inflammatory Skin Diseases Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Inflammatory Skin Diseases Drugs Headquarters, Revenue in Inflammatory Skin Diseases Drugs Business (2017-2022) & (US$ Million) Type 4.3.1 Global Inflammatory Skin Diseases Drugs Headquarters and Area Served 4.3.2 Global Inflammatory Skin Diseases Drugs Companies Revenue in Inflammatory Skin Diseases Drugs Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Inflammatory Skin Diseases Drugs Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Inflammatory Skin Diseases Drugs Market Size by Company 4.5.1 Top Inflammatory Skin Diseases Drugs Players in United States, Ranked by Revenue (2021) 4.5.2 United States Inflammatory Skin Diseases Drugs Revenue by Players (2020, 2021 & 2022) 5 Global Inflammatory Skin Diseases Drugs Market Size by Region 5.1 Global Inflammatory Skin Diseases Drugs Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Inflammatory Skin Diseases Drugs Market Size by Region (2017-2028) 5.2.1 Global Inflammatory Skin Diseases Drugs Market Size by Region: 2017-2022 5.2.2 Global Inflammatory Skin Diseases Drugs Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Inflammatory Skin Diseases Drugs Market Size YoY Growth 2017-2028 6.1.2 North America Inflammatory Skin Diseases Drugs Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Inflammatory Skin Diseases Drugs Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Inflammatory Skin Diseases Drugs Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Inflammatory Skin Diseases Drugs Market Size YoY Growth 2017-2028 6.3.2 Europe Inflammatory Skin Diseases Drugs Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Inflammatory Skin Diseases Drugs Market Size YoY Growth 2017-2028 6.4.2 Latin America Inflammatory Skin Diseases Drugs Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Inflammatory Skin Diseases Drugs Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Inflammatory Skin Diseases Drugs Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Pfizer 7.1.1 Pfizer Company Details 7.1.2 Pfizer Business Overview 7.1.3 Pfizer Inflammatory Skin Diseases Drugs Introduction 7.1.4 Pfizer Revenue in Inflammatory Skin Diseases Drugs Business (2017-2022) 7.1.5 Pfizer Recent Development 7.2 Merck 7.2.1 Merck Company Details 7.2.2 Merck Business Overview 7.2.3 Merck Inflammatory Skin Diseases Drugs Introduction 7.2.4 Merck Revenue in Inflammatory Skin Diseases Drugs Business (2017-2022) 7.2.5 Merck Recent Development 7.3 AbbVie 7.3.1 AbbVie Company Details 7.3.2 AbbVie Business Overview 7.3.3 AbbVie Inflammatory Skin Diseases Drugs Introduction 7.3.4 AbbVie Revenue in Inflammatory Skin Diseases Drugs Business (2017-2022) 7.3.5 AbbVie Recent Development 7.4 Novartis 7.4.1 Novartis Company Details 7.4.2 Novartis Business Overview 7.4.3 Novartis Inflammatory Skin Diseases Drugs Introduction 7.4.4 Novartis Revenue in Inflammatory Skin Diseases Drugs Business (2017-2022) 7.4.5 Novartis Recent Development 7.5 Boehringer Ingelheim 7.5.1 Boehringer Ingelheim Company Details 7.5.2 Boehringer Ingelheim Business Overview 7.5.3 Boehringer Ingelheim Inflammatory Skin Diseases Drugs Introduction 7.5.4 Boehringer Ingelheim Revenue in Inflammatory Skin Diseases Drugs Business (2017-2022) 7.5.5 Boehringer Ingelheim Recent Development 7.6 Amgen 7.6.1 Amgen Company Details 7.6.2 Amgen Business Overview 7.6.3 Amgen Inflammatory Skin Diseases Drugs Introduction 7.6.4 Amgen Revenue in Inflammatory Skin Diseases Drugs Business (2017-2022) 7.6.5 Amgen Recent Development 7.7 Eli Lilly 7.7.1 Eli Lilly Company Details 7.7.2 Eli Lilly Business Overview 7.7.3 Eli Lilly Inflammatory Skin Diseases Drugs Introduction 7.7.4 Eli Lilly Revenue in Inflammatory Skin Diseases Drugs Business (2017-2022) 7.7.5 Eli Lilly Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Inflammatory Skin Diseases Drugs Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Inflammatory Skin Diseases Drugs Market Trends Table 3. Inflammatory Skin Diseases Drugs Market Drivers Table 4. Inflammatory Skin Diseases Drugs Market Challenges Table 5. Inflammatory Skin Diseases Drugs Market Restraints Table 6. Global Inflammatory Skin Diseases Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Inflammatory Skin Diseases Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Inflammatory Skin Diseases Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Inflammatory Skin Diseases Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Inflammatory Skin Diseases Drugs Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Inflammatory Skin Diseases Drugs Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Inflammatory Skin Diseases Drugs Revenue Share by Player, 2017-2022 Table 13. Global Inflammatory Skin Diseases Drugs Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Inflammatory Skin Diseases Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Skin Diseases Drugs as of 2021) Table 15. Top Players of Inflammatory Skin Diseases Drugs in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Inflammatory Skin Diseases Drugs Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Inflammatory Skin Diseases Drugs Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Inflammatory Skin Diseases Drugs Players in United States Market, Ranking by Revenue (2021) Table 20. United States Inflammatory Skin Diseases Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Inflammatory Skin Diseases Drugs Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Inflammatory Skin Diseases Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Inflammatory Skin Diseases Drugs Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Inflammatory Skin Diseases Drugs Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Inflammatory Skin Diseases Drugs Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Inflammatory Skin Diseases Drugs Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Inflammatory Skin Diseases Drugs Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Inflammatory Skin Diseases Drugs Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Inflammatory Skin Diseases Drugs Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Pfizer Company Details Table 31. Pfizer Business Overview Table 32. Pfizer Inflammatory Skin Diseases Drugs Product Table 33. Pfizer Revenue in Inflammatory Skin Diseases Drugs Business (2017-2022) & (US$ Million) Table 34. Pfizer Recent Development Table 35. Merck Company Details Table 36. Merck Business Overview Table 37. Merck Inflammatory Skin Diseases Drugs Product Table 38. Merck Revenue in Inflammatory Skin Diseases Drugs Business (2017-2022) & (US$ Million) Table 39. Merck Recent Development Table 40. AbbVie Company Details Table 41. AbbVie Business Overview Table 42. AbbVie Inflammatory Skin Diseases Drugs Product Table 43. AbbVie Revenue in Inflammatory Skin Diseases Drugs Business (2017-2022) & (US$ Million) Table 44. AbbVie Recent Development Table 45. Novartis Company Details Table 46. Novartis Business Overview Table 47. Novartis Inflammatory Skin Diseases Drugs Product Table 48. Novartis Revenue in Inflammatory Skin Diseases Drugs Business (2017-2022) & (US$ Million) Table 49. Novartis Recent Development Table 50. Boehringer Ingelheim Company Details Table 51. Boehringer Ingelheim Business Overview Table 52. Boehringer Ingelheim Inflammatory Skin Diseases Drugs Product Table 53. Boehringer Ingelheim Revenue in Inflammatory Skin Diseases Drugs Business (2017-2022) & (US$ Million) Table 54. Boehringer Ingelheim Recent Development Table 55. Amgen Company Details Table 56. Amgen Business Overview Table 57. Amgen Inflammatory Skin Diseases Drugs Product Table 58. Amgen Revenue in Inflammatory Skin Diseases Drugs Business (2017-2022) & (US$ Million) Table 59. Amgen Recent Development Table 60. Eli Lilly Company Details Table 61. Eli Lilly Business Overview Table 62. Eli Lilly Inflammatory Skin Diseases Drugs Product Table 63. Eli Lilly Revenue in Inflammatory Skin Diseases Drugs Business (2017-2022) & (US$ Million) Table 64. Eli Lilly Recent Development Table 65. Research Programs/Design for This Report Table 66. Key Data Information from Secondary Sources Table 67. Key Data Information from Primary Sources List of Figures Figure 1. Inflammatory Skin Diseases Drugs Product Picture Figure 2. Global Inflammatory Skin Diseases Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Inflammatory Skin Diseases Drugs Market Size 2017-2028 (US$ Million) Figure 4. United States Inflammatory Skin Diseases Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Inflammatory Skin Diseases Drugs Market Size 2017-2028 (US$ Million) Figure 6. United States Inflammatory Skin Diseases Drugs Market Share in Global 2017-2028 Figure 7. Inflammatory Skin Diseases Drugs Report Years Considered Figure 8. Product Picture of Retinoids Figure 9. Product Picture of Corticosteroids Figure 10. Product Picture of Calcineurin Inhibitors Figure 11. Product Picture of Others Figure 12. Global Inflammatory Skin Diseases Drugs Market Share by Type in 2022 & 2028 Figure 13. Global Inflammatory Skin Diseases Drugs Market Size by Type (2017-2028) & (US$ Million) Figure 14. Global Inflammatory Skin Diseases Drugs Market Share by Type (2017-2028) Figure 15. United States Inflammatory Skin Diseases Drugs Market Share by Type in 2022 & 2028 Figure 16. United States Inflammatory Skin Diseases Drugs Market Size by Type (2017-2028) & (US$ Million) Figure 17. United States Inflammatory Skin Diseases Drugs Market Share by Type (2017-2028) Figure 18. Product Picture of Hospital Pharmacies Figure 19. Product Picture of Retail Pharmacies Figure 20. Product Picture of Online Pharmacies Figure 21. Global Inflammatory Skin Diseases Drugs Market Share by Application in 2022 & 2028 Figure 22. Global Inflammatory Skin Diseases Drugs Market Size by Application (2017-2028) & (US$ Million) Figure 23. Global Inflammatory Skin Diseases Drugs Market Share by Application (2017-2028) Figure 24. United States Inflammatory Skin Diseases Drugs Market Share by Application in 2022 & 2028 Figure 25. United States Inflammatory Skin Diseases Drugs Market Size by Application (2017-2028) & (US$ Million) Figure 26. United States Inflammatory Skin Diseases Drugs Market Share by Application (2017-2028) Figure 27. North America Inflammatory Skin Diseases Drugs Market Size Growth Rate 2017-2028 (US$ Million) Figure 28. U.S. Inflammatory Skin Diseases Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 29. Canada Inflammatory Skin Diseases Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. Europe Inflammatory Skin Diseases Drugs Market Size Growth Rate 2017-2028 (US$ Million) Figure 31. Germany Inflammatory Skin Diseases Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. France Inflammatory Skin Diseases Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. U.K. Inflammatory Skin Diseases Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Italy Inflammatory Skin Diseases Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 35. Russia Inflammatory Skin Diseases Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Asia-Pacific Inflammatory Skin Diseases Drugs Market Size Growth Rate 2017-2028 (US$ Million) Figure 37. China Inflammatory Skin Diseases Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. Japan Inflammatory Skin Diseases Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. South Korea Inflammatory Skin Diseases Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. India Inflammatory Skin Diseases Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Australia Inflammatory Skin Diseases Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Taiwan Inflammatory Skin Diseases Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Indonesia Inflammatory Skin Diseases Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Thailand Inflammatory Skin Diseases Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Malaysia Inflammatory Skin Diseases Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Philippines Inflammatory Skin Diseases Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Latin America Inflammatory Skin Diseases Drugs Market Size Growth Rate 2017-2028 (US$ Million) Figure 48. Mexico Inflammatory Skin Diseases Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Brazil Inflammatory Skin Diseases Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Argentina Inflammatory Skin Diseases Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Middle East & Africa Inflammatory Skin Diseases Drugs Market Size Growth Rate 2017-2028 (US$ Million) Figure 52. Turkey Inflammatory Skin Diseases Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. Saudi Arabia Inflammatory Skin Diseases Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 54. U.A.E Inflammatory Skin Diseases Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 55. Pfizer Revenue Growth Rate in Inflammatory Skin Diseases Drugs Business (2017-2022) Figure 56. Merck Revenue Growth Rate in Inflammatory Skin Diseases Drugs Business (2017-2022) Figure 57. AbbVie Revenue Growth Rate in Inflammatory Skin Diseases Drugs Business (2017-2022) Figure 58. Novartis Revenue Growth Rate in Inflammatory Skin Diseases Drugs Business (2017-2022) Figure 59. Boehringer Ingelheim Revenue Growth Rate in Inflammatory Skin Diseases Drugs Business (2017-2022) Figure 60. Amgen Revenue Growth Rate in Inflammatory Skin Diseases Drugs Business (2017-2022) Figure 61. Eli Lilly Revenue Growth Rate in Inflammatory Skin Diseases Drugs Business (2017-2022) Figure 62. Bottom-up and Top-down Approaches for This Report Figure 63. Data Triangulation Figure 64. Key Executives Interviewed

Pfizer Merck AbbVie Novartis Boehringer Ingelheim Amgen Eli Lilly